Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Xiomara Garza Vazquez
Observed names:
X Vázquez,
X. Garza Vazquez
Institutions:
Friedrich-Alexander-Universität Erlangen-Nürnberg,
LMU Klinikum,
Universitätsklinikum Erlangen,
Ludwig-Maximilians-Universität München
Observed institutions:
Universidad de la República de Uruguay,
Friedrich-Alexander-Universität Erlangen-Nürnberg,
LMU Klinikum,
Universitätsklinikum Erlangen,
Hospital de Clínicas,
Ludwig-Maximilians-Universität München
show all 6
ORCID:
0009-0003-0037-5283
Observed ORCID:
0009-0003-0037-5283
OpenAlex ID:
A5016045142
Extracorporeal photopheresis vs. systemic immunosuppression for immune-related adverse events: Interim analysis of a prospective two-arm study
2024
·
C. Ertl
, T. Ruf
, et al.
·
European Journal of Cancer
·
17
PDF
Extracorporeal photopheresis versus systemic immunosuppression for treatment of immune-related adverse events: clinical outcomes from the prospective two-arm PRIA study
2026
·
Lisa Wein
, Carolin Ertl
, et al.
·
Journal for ImmunoTherapy of Cancer
·
2
Admissions to a University Hospital for Adverse Drug Reactions and Patient’s Interruption of Treatment
2007
·
G Giachetto
, A Danza
, et al.
·
Drug Safety
·
2
Real-world data on anti-PD-1 plus lenvatinib as a treatment option in pretreated advanced melanoma patients - a retrospective DeCOG study
2026
·
Lea Jessica Albrecht
, Jana Garnier
, et al.
·
European Journal of Cancer
·
1
Abstract LB421: Extracorporeal photopheresis vs. systemic immunosuppression for treatment of immune-related adverse events: Final analysis of the prospective two-arm PRIA study
2026
·
Lisa Wein
, Carolin Ertl
, et al.
·
Cancer Research
Show more works
View as search
Works count:
5
Citation count:
22
H-index:
2
I10-index:
1
Year
Topic
Type